158 related articles for article (PubMed ID: 31789429)
1. FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence.
Zhang W; Liu H; Deng XD; Ma Y; Liu Y
Ann Hum Genet; 2020 May; 84(3):259-270. PubMed ID: 31789429
[TBL] [Abstract][Full Text] [Related]
2. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
Liu H; Zhang W; Deng XD; Ma Y; Liu Y
Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
[TBL] [Abstract][Full Text] [Related]
3. Association of GABA receptor delta subunit gene variations with increased risk of methamphetamine dependence.
Xie X; Zhuang D; Gu J; Wu T; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H
Neurosci Lett; 2023 Mar; 800():137137. PubMed ID: 36804572
[TBL] [Abstract][Full Text] [Related]
4. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.
Morita Y; Ujike H; Tanaka Y; Uchida N; Nomura A; Ohtani K; Kishimoto M; Morio A; Imamura T; Sakai A; Inada T; Harano M; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
Neurosci Lett; 2005 Mar; 376(3):182-7. PubMed ID: 15721218
[TBL] [Abstract][Full Text] [Related]
5. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
[TBL] [Abstract][Full Text] [Related]
6. Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.
Sim MS; Hatim A; Reynolds GP; Mohamed Z
Pharmacogenomics; 2013 Apr; 14(5):505-14. PubMed ID: 23556448
[TBL] [Abstract][Full Text] [Related]
7. The influence of the fatty acid amide hydrolase 385C>A single nucleotide polymorphisms on obesity susceptibility.
Yagin NL; Aliasgari F; Aliasgharzadeh S; Mahdavi R; Akbarzadeh M
Mol Biol Rep; 2019 Oct; 46(5):5049-5055. PubMed ID: 31286394
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings.
Gupta S; Bousman CA; Chana G; Cherner M; Heaton RK; Deutsch R; Ellis RJ; Grant I; Everall IP
J Neurovirol; 2011 Jun; 17(3):239-47. PubMed ID: 21491142
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.
Iamjan SA; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S
J Psychopharmacol; 2018 Mar; 32(3):309-315. PubMed ID: 29338492
[TBL] [Abstract][Full Text] [Related]
10. Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome.
Jiang Y; Nie Y; Li Y; Zhang L
J Gastroenterol Hepatol; 2014 Jun; 29(6):1186-91. PubMed ID: 24444427
[TBL] [Abstract][Full Text] [Related]
11. The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population.
Kobayashi H; Ujike H; Iwata N; Inada T; Yamada M; Sekine Y; Uchimura N; Iyo M; Ozaki N; Itokawa M; Sora I
Behav Brain Funct; 2010 Aug; 6():50. PubMed ID: 20799992
[TBL] [Abstract][Full Text] [Related]
12. BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence.
Iamjan SA; Thanoi S; Watiktinkorn P; Nudmamud-Thanoi S; Reynolds GP
Pharmacogenomics; 2015; 16(14):1541-5. PubMed ID: 26401760
[TBL] [Abstract][Full Text] [Related]
13. The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women.
Monteleone P; Tortorella A; Martiadis V; Di Filippo C; Canestrelli B; Maj M
Psychoneuroendocrinology; 2008 May; 33(4):546-50. PubMed ID: 18295974
[TBL] [Abstract][Full Text] [Related]
14. [Association of polymorphisms of NAPE-PLD and FAAH genes with schizophrenia in Chinese Han population].
Si P; Liu S; Tong D; Cheng M; Wang L; Cheng X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):215-218. PubMed ID: 29652995
[TBL] [Abstract][Full Text] [Related]
15. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.
Monteleone P; Bifulco M; Di Filippo C; Gazzerro P; Canestrelli B; Monteleone F; Proto MC; Di Genio M; Grimaldi C; Maj M
Genes Brain Behav; 2009 Oct; 8(7):728-32. PubMed ID: 19659925
[TBL] [Abstract][Full Text] [Related]
16. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.
Kishi T; Tsunoka T; Ikeda M; Kitajima T; Kawashima K; Okochi T; Okumura T; Yamanouchi Y; Kinoshita Y; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
Neuropharmacology; 2010 Feb; 58(2):452-6. PubMed ID: 19747927
[TBL] [Abstract][Full Text] [Related]
17. Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependence.
Veerasakul S; Watiktinkorn P; Thanoi S; Reynolds GP; Nudmamud-Thanoi S
Pharmacogenomics; 2017 Jan; 18(1):17-22. PubMed ID: 27967329
[TBL] [Abstract][Full Text] [Related]
18. PROKR2 is associated with methamphetamine dependence in the Japanese population.
Kishi T; Kitajima T; Tsunoka T; Okumura T; Okochi T; Kawashima K; Inada T; Ujike H; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1033-6. PubMed ID: 20576534
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
Monteleone P; Milano W; Petrella C; Canestrelli B; Maj M
J Clin Psychopharmacol; 2010 Aug; 30(4):441-5. PubMed ID: 20631561
[TBL] [Abstract][Full Text] [Related]
20. Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.
Ikeda M; Okahisa Y; Aleksic B; Won M; Kondo N; Naruse N; Aoyama-Uehara K; Sora I; Iyo M; Hashimoto R; Kawamura Y; Nishida N; Miyagawa T; Takeda M; Sasaki T; Tokunaga K; Ozaki N; Ujike H; Iwata N
Neuropsychopharmacology; 2013 Sep; 38(10):1864-70. PubMed ID: 23594818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
